Synlett 2015; 26(06): 846-850
DOI: 10.1055/s-0034-1380144
letter
© Georg Thieme Verlag Stuttgart · New York

Efficient Synthesis of Highly Enantioenriched Δ1-Pyrrolines

Diana I. S. P. Resende
a   Department of Chemistry, QOPNA, University of Aveiro, 3810-193 Aveiro, Portugal
,
Samuel Guieu
a   Department of Chemistry, QOPNA, University of Aveiro, 3810-193 Aveiro, Portugal
b   Department of Chemistry, CICECO, University of Aveiro, 3810-193 Aveiro, Portugal   Email: artur.silva@ua.pt
,
Cristina G. Oliva*
a   Department of Chemistry, QOPNA, University of Aveiro, 3810-193 Aveiro, Portugal
,
Artur M. S. Silva*
a   Department of Chemistry, QOPNA, University of Aveiro, 3810-193 Aveiro, Portugal
› Author Affiliations
Further Information

Publication History

Received: 27 November 2014

Accepted after revision: 14 January 2015

Publication Date:
17 February 2015 (online)


Abstract

A general and efficient asymmetric synthesis of Δ1-pyrrolines by a one-pot nitro-reduction, cyclization, and dehydration of (R,E)-1,5-diphenyl-3-(nitromethyl)-5-pent-4-en-1-ones with iron and aqueous hydrochloric acid has been developed. The Δ1-pyrrolines were obtained with excellent enantioselectivities (up to 99%) and high yields (up to 83%).

Supporting Information

 
  • References and Notes

  • 1 Current address: Medicinal Chemistry Section, Experimental Therapeutics Programme, CNIO (Spanish National Cancer Research Centre), Madrid, Spain.
  • 2 Huang P.-Q. Asymmetric Synthesis of Five Membered Ring Heterocycles. In Asymmetric Synthesis of Nitrogen Heterocycles. Royer J. Wiley-VCH; Weinheim: 2009
  • 3 Pinder AR. Nat. Prod. Rep. 1992; 9: 491
  • 4 Asghari S, Qandalee M. Synth. Commun. 2010; 40: 2172
  • 5 Cardona F, Rocha J, Silva AM. S, Guieu S. Dyes Pigm. 2014; 111: 16
  • 6 Marrec O, Christophe C, Billard T, Langlois B, Vors J.-P, Pazenok S. Adv. Synth. Catal. 2010; 352: 2825
  • 7 Shvekhgeimer MG. A. Chem. Heterocycl. Compd. 2003; 39: 405
  • 8 Black DS, Edwards GL, Evans RH, Keller PA, Laaman SM. Tetrahedron 2000; 56: 1889
  • 9 Liang Y, Dong D, Lu Y, Wang Y, Pan W, Chai Y, Liu Q. Synthesis 2006; 3301
  • 10 Kawai H, Kitayama T, Tokunaga E, Matsumoto T, Sato H, Shiro M, Shibata N. Chem. Commun. 2012; 48: 4067
  • 11 Lee M, Lee Y.-J, Park E, Park Y, Ha MW, Hong S, Lee Y.-J, Kim T.-S, Kim M.-h, Park H.-g. Org. Biomol. Chem. 2013; 11: 2039
  • 12 Oliva CG, Silva AM. S, Paz FA. A, Cavaleiro JA. S. Synlett 2010; 1123
  • 13 Oliva CG, Silva AM. S, Resende DI. S. P, Paz FA. A, Cavaleiro JA. S. Eur. J. Org. Chem. 2010; 3449
  • 14 Silva EM. P, Silva AM. S, Cavaleiro JA. S. Synlett 2011; 2740
  • 15 A mixture of iron powder (30 g) and 10% HCl (25 mL) was stirred vigorously for 1 min. The solution was then filtered off and the iron powder was washed successively with distilled water (5 × 25 mL) and absolute EtOH (5 × 25 mL).
  • 16 Synthesis of 4a–h; General Procedure: To a solution of (R,E)-1,5-diaryl-3-(nitromethyl)-5-pent-4-en-1-ones 3ah (0.31 mmol) in a mixture of THF–MeOH (2:1, 6 mL) was successively added at r.t., AcOH (4.98 mmol) and activated iron powder (14.0 mmol). The resulting mixture was heated at 65 °C for 15 h under a nitrogen atmosphere. After cooling to r.t., the reaction mixture was filtered through Celite and rinsed with EtOAc. The resultant solution was washed with sat. aq NaHCO3, brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was purified by column chromatography (hexane–EtOAc, 80:20). Finally the residues were crystallized from hexane–EtOAc to furnish the desired compounds 4ah. Compound 4a: Yield: 72%; brown oil. 1H NMR (300 MHz, CDCl3): δ = 7.85 (dd, J = 7.0, 2.3 Hz, 2 H, H-2′,6′), 7.45–7.19 (m, 8 H, H-3′,5′, H-4′, H-2′′,6′′, H-3′′,5′′, H-4′′), 6.47 (d, J = 15.8 Hz, 1 H, H-β), 6.24 (dd, J = 15.8, 7.9 Hz, 1 H, H-α), 4.33 (dd, J = 15.6, 7.2 Hz, 2 H, H-5), 3.90 (dd, J = 15.6, 5.1 Hz, 1 H, H-5), 3.36–3.19 (m, 2 H, H-3, H-4), 2.97–2.81 (m, 1 H, H-3). 13C NMR (75 MHz, CDCl3): δ = 172.7 (C-2), 137.1 (C-1′′), 134.2 (C-1′), 132.2 (C-α), 130.5 (C-4′), 129.9 (C-β), 128.5 (C-3′,5′,C-3′′,5′′), 127.5 (C-2′,6′), 127.2 (C-4′′), 126.0 (C-2′′,6′′), 67.2 (C-5), 41.8 (C-3), 41.3 (C-4). HRMS (ESI+): m/z [C18H17N + H]+ calcd for C19H17N: 248.1434; found: 248.1433. HPLC (i-PrOH–hexane, 10:90; flow rate 0.7 mL/min; λ = 254 nm): t r = 10.90 [(R)-4a] min (ee = 99%). Compound 4e: Yield: 44%; salmon solid; mp 110.6–111.3 °C. 1H NMR (300 MHz, CDCl3): δ = 7.71 (d, J = 8.6 Hz, 2 H, H-2′,6′), 7.55 (d, J = 8.6 Hz, 2 H, H-3′,5′), 7.37–7.18 (m, 5 H, H-2′′,6′′, H-3′′,5′′, H-4′′), 6.46 (d, J = 15.8 Hz, 1 H, H-β), 6.23 (dd, J = 15.8, 8.2 Hz, 1 H, H-α), 4.38–4.24 (m, 1 H, H-5), 3.94–3.82 (m, 1 H, H-5), 3.38–3.16 (m, 2 H, H-3, H-4), 2.92–2.79 (m, 1 H, H-3). 13C NMR (75 MHz, CDCl3): δ = 171.8 (C-2), 137.0 (C-1′′), 133.2 (C-4′), 132.0 (C-α), 131.7 (C-3′,5′), 130.2 (C-β), 129.1 (C-2′,6′), 128.6 (C-3′′,5′′), 127.4 (C-4′′), 126.1 (C-2′′,6′′), 125.1 (C-1′), 67.4 (C-5), 41.8 (C-3), 41.4 (C-4). HRMS (ESI+): m/z [C18H16BrN + H]+ calcd for C18H17BrN: 326.0539; found: 326.0537. HPLC (i-PrOH–hexane, 10:90; flow rate 0.7 mL/min; λ = 254 nm): t r = 13.07 [(R)-4e] min (ee = 99%).
  • 17 Crystal data for 4d: C18H16ClN; M = 281.77; orthorhombic; space group P212121; Z = 4; a = 5.6675(7) Å, b = 7.8846(12) Å, c = 32.643(3) Å, α = β = γ = 90.00°; V = 1458.7(3) Å3; colorless crystal with crystal size of 0.10 × 0.08 × 0.04 mm was used. Of a total of 2942 reflections collected, 2022 were independent (Rint = 0.0968). Final R1 = 0.0614 [I > 2σ(I)] and wR2 = 0.1591 (all data). Crystal data for 4e: C18H16FN; M = 265.32; orthorhombic; space group P212121; Z = 4; a = 5.6544(6) Å, b = 7.9709(8) Å, c = 31.048(3) Å, α = β = γ = 90.00°; V = 1399.4(2) Å3; colourless flake with crystal size of 0.50 × 0.20 × 0.04 mm. Of a total of 3068 reflections collected, 2834 were independent (Rint = 0.0380). Final R1 = 0.0336 [I > 2σ(I)] and wR2 = 0.0796 (all data). CCDC-1033064 and 1033065 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/datarequest/cif.